Deutsch English Français

Contact

EP1539104

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1539104

EP1539104 - USE OF IV EMULSIONS WITH DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 11.11.2005 Database last updated on 25.09.2024
Most recent event Tooltip	02.05.2008	Change - representative	published on 04.06.2008 [2008/23]
Applicant(s)	For all designated states The Trustees of Columbia University in the City of New York West 116th Street and Broadway New York New York 10027 / US
	[N/P]
Former [2005/24]	For all designated states THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK West 116th Street and Broadway New York, New York 10027 / US
Inventor(s)	01 / DECKELBAUM, Richard, J. P.O. Box 651 Hastings-on-Hudson, NY 10706 / US
	02 / CARPENTIER, A., Yvon Rue de Percke 110 B-1180 Brussels / BE
	[2005/24]
Representative(s)	Lawrence, John Barker Brettell LLP 100 Hagley Road Edgbaston Birmingham B16 8QQ / GB
	[N/P]
Former [2008/23]	Lawrence, John Barker Brettell LLP 138 Hagley Road Edgbaston Birmingham B16 9PW / GB
Former [2005/24]	Lawrence, John Barker, Brettell 138 Hagley Road Edgbaston Birmingham B16 9PW / GB
Application number, filing date	01988430.3	28.12.2001
	[2005/24]
	WO2001US50828
Priority number, date	US20000258654P	29.12.2000 Original published format: US 258654 P
	[2005/24]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO02053102
	Date:	11.07.2002
	Language:	EN
	[2002/28]
	Type:	A2 Application without search report
	No.:	EP1539104
	Date:	15.06.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.07.2002 takes the place of the publication of the European patent application.
	[2005/24]
Search report(s)	International search report - published on:	US	31.03.2005
	(Supplementary) European search report - dispatched on:	EP	29.03.2005
Classification	IPC:	A61K9/10	[2005/24]
	CPC:	A61K9/1075 (EP,US)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2005/24]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	VERWENDUNG VON IV-EMULSIONEN MIT UNTERSCHIEDLICHER TRIGLYCERID-ZUSAMMENSETZUNG, TEILCHENGRÖSSE UND APOLIPOPROTEIN E FÜR DIE GEZIELTE GEWEBEABGABE VON HYDROPHOBEN VERBINDUNGEN	[2005/24]
	English:	USE OF IV EMULSIONS WITH DIFFERENT TRIGLYCERIDE COMPOSITION, PARTICLE SIZE AND APOLIPOPROTEIN E FOR TARGETED TISSUE DELIVERY OF HYDROPHOBIC COMPOUNDS	[2005/24]
	French:	UTILISATION DE IV EMULSIONS COMPOSEES DE DIFFERENTS TRIGLYCERIDES, DE DIFFERENTES TAILLE DE PARTICULES, ET D'APOLIPOPROTEINES E, POUR L'ADMINISTRATION DE COMPOSES HYDROPHOBES A DES TISSUS CIBLES	[2005/24]
Entry into regional phase	29.07.2003	National basic fee paid
	29.07.2003	Search fee paid
	29.07.2003	Designation fee(s) paid
	29.07.2003	Examination fee paid
Examination procedure	25.07.2002	Request for preliminary examination filed International Preliminary Examining Authority: US
	29.07.2003	Examination requested [2005/24]
	27.07.2005	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2005/52]
	28.09.2005	Application deemed to be withdrawn, date of legal effect [2005/52]
Fees paid	Renewal fee
	17.11.2003	Renewal fee patent year 03
	17.11.2004	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]DE4217842 (DIETL HANS [DE]) [X] 1-3,10-14,21-23,26 * example 2 *;
		[X]WO9929316 (SEVERSON MARY L [US], et al) [X] 1-3,10-14,21-23,26 * page 1, lines 4-9 * * page 5, lines 12-17 * * page 7, lines 1-14 * * examples 11,12 *;
		[X]US6008248 (PSCHERER GERMAN [DE], et al) [X] 1-3,6-14,21-23,26,28 * column 4, lines 46-50 * * column 5, lines 6-25 * * table 2 *;
		[X] - LINSEISEN J ET AL, "Antioxidant status of surgical patients receiving TPN with an OMEGA-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol", CLINICAL NUTRITION (EDINBURGH), (200006), vol. 19, no. 3, ISSN 0261-5614, pages 177 - 184, XP002310729 [X] 1-3,6-14,21-23,26,28 * table 2 * * page 181, column 1, paragraph L - column 2, paragraph 1 *
		[DA] - TRESKOVA E ET AL, "BLOOD CLEARANCE AND TISSUE UPTAKE OF INTRAVENOUS LIPID EMULSIONS CONTAINING LONG-CHAIN AND MEDIUM-CHAIN TRIGLYCERIDES AND FISH OIL IN A MOUSE MODEL", JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, AMERICAN SOCIETY FOR PARENTERAL AND ENTERAL NUTRITION, US, (200009), vol. 23, no. 5, ISSN 0148-6071, pages 253 - 257, XP001053210 [DA] 1-3,6-14,21-23,26,28 * figures 1-3 *
	International search	[Y]US5650172 (MATSUDA SABURO [JP], et al);
		[Y]US5789399 (STRUBE MARILYN E [US]);
		[Y]WO9531181 (UNIV MICHIGAN [US], et al);
		[Y]US5028600 (JEPPSSON ROLAND I [SE]);
		[Y]WO9221335 (KABI PHARMACIA AB [SE])
		[Y] - RENSEN ET AL., "Particle size determinates the specificity of apolopoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo", JOURNAL OF LIPID RESEARCH, vol. 38, pages 1070 - 1084

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p